Article info
PDFPostScript
Correspondence
Outcome of national oversight of intravenous immunoglobulin prescribing in immune thrombocytopenia
- Correspondence to Dr Siraj A Misbah, Immunology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK; siraj.misbah{at}ouh.nhs.uk
Citation
Outcome of national oversight of intravenous immunoglobulin prescribing in immune thrombocytopenia
Publication history
- Received August 18, 2020
- Revised October 1, 2020
- Accepted October 7, 2020
- First published October 22, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.